Further studies are warranted to clarify the exact immunological setting of Tregs in the intestinal mucosa of IBD patients before and after anti-TNFα treatments, as well as the functional properties of Tregs in these patients, and in particular their suppressive ability. Here, TNF is linked to inflammatory bowel disease.